Table 2 Details of the differential metabolites between the SECC and CF groups
From: Salivary microbiome and metabolome analysis of severe early childhood caries
Compounds | Formula | VIP | Log2FC | Type |
|---|---|---|---|---|
Acetylpseudotropine | C10H17NO2 | 1.35 | 9.81 | Up |
3-Indoleacrylic acid | C11H9NO2 | 1.98 | 0.62 | Up |
2-Formaminobenzoylacetate | C10H9NO4 | 2.15 | 0.86 | Up |
Cytidine | C9H13N3O5 | 1.66 | 0.73 | Up |
Guanosine | C10H13N5O5 | 2.30 | 0.73 | Up |
Stachydrine | C7H13NO2 | 1.07 | 0.63 | Up |
Epinephrine | C9H13NO3 | 1.77 | 1.03 | Up |
Ala Tyr Thr Lys | C22H35N5O7 | 2.12 | 0.87 | Up |
Arg Ser Ser | C12H24N6O6 | 2.06 | 1.05 | Up |
Pro Pro His | C16H23N5O4 | 2.03 | 0.86 | Up |
L-Erythrulose 4-phosphate | C4H9O7P | 1.35 | − 0.72 | Down |
Phe Gln Val | C19H28N4O5 | 1.87 | 1.18 | Up |
Mepirizole | C11H14N4O2 | 2.56 | 0.86 | Up |
3-beta-D-Galactosyl-sn-glycerol;Galactosylglycerol | C9H18O8 | 1.32 | − 0.61 | Down |
N-Methylephedrine | C11H17NO | 1.36 | 9.68 | Up |
Dodecylbenzenesulfonic acid | C18H30O3S | 2.00 | 0.84 | Up |
Gln Arg Leu | C17H33N7O5 | 1.93 | 0.88 | Up |
Arg Thr Ala Arg | C19H38N10O6 | 2.02 | 0.77 | Up |
PC(16:0/16:0) | C40H75NO9 | 1.06 | − 0.71 | Down |
Lys Met His | C17H30N6O4S1 | 1.51 | − 0.83 | Down |
Leu Val Leu Gly Phe | C28H45N5O6 | 1.42 | 2.57 | Up |
Alangicine | C28H36N2O5 | 2.00 | 0.79 | Up |
2-Benzylmalate | C11H12O5 | 1.24 | 1.08 | Up |
Hexaethylene glycol | C12H26O7 | 2.16 | 1.15 | Up |
Ethyl-L-NIO | C9H19N3O2 | 1.90 | 1.17 | Up |
(2S)-N-[(2S)-1-hydroxy-3-(1H-indol-3-yl)propan-2-yl]-3-methyl-2-(methylamino)butanamide | C17H25N3O2 | 2.27 | 1.12 | Up |
Bucladesine | C18H24N5O8P | 2.23 | 1.62 | Up |
Val Pro Val | C15H27N3O4 | 1.60 | − 0.96 | Down |
1,2,4-Oxadiazole, 5-[4-phenyl-5-(trifluoromethyl)-2-thienyl]-3-[3-(trifluoromethyl)phenyl]- | C20H10F6N2OS | 1.43 | − 1.03 | Down |
Uridine 5'-diphosphate | C9H14N2O12P2 | 1.23 | − 0.67 | Down |
1,2-Dibenzoylbenzene | C20H14O2 | 1.93 | 0.60 | Up |
Fluazinam | C13H4Cl2F6N4O4 | 1.33 | − 0.86 | Down |